Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER3 | P43115 | 3/20 | 0.59 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.59 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.59 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | PPIA | P62937 | 1/20 | 0.49 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.48 |
| ▸ | TFEB | P19484 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2961596 | 0.87 | PTGER4 (0.61) | PTGER3PTGER4PTGER2PTGER1HTT | |
| SCHEMBL2961597 | 0.87 | PTGER4 (0.61) | PTGER3PTGER4PTGER2PTGER1HTT | |
| SCHEMBL5078092 | 0.85 | PTGER1 (0.62) | PTGER3PTGER4PTGER2PTGER1HTT | |
| SCHEMBL9716888 | 0.85 | PTGER1 (0.62) | PTGER3PTGER4PTGER2PTGER1HTT | |
| SCHEMBL5178116 | 0.84 | PTGER1 (0.61) | PTGER3PTGER4PTGER2PTGER1HTT | |
| SCHEMBL1356220 | 0.83 | PTGER1 (0.64) | PTGER3PTGER4PTGER2PTGER1HTT | |
| SCHEMBL14843147 | 0.83 | PTGER1 (0.64) | PTGER3PTGER4PTGER2PTGER1HTT | |
| SCHEMBL11685411 | 0.83 | PTGER4 (0.64) | PTGER3PTGER4PTGER2PTGER1HTT | |
| SCHEMBL4331860 | 0.82 | PTGER1 (0.59) | PTGER3PTGER4PTGER2PTGER1HTT | |
| SCHEMBL4331862 | 0.82 | PTGER1 (0.59) | PTGER3PTGER4PTGER2PTGER1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3154510-B1 | COMPOSITION FOR PROTECTING KERATIN MATERIALS FROM SUN | OREAL (FR) | 2022-01-19 | — | — | EP | claimed |
| EP-3107526-B1 | TOPICAL ANHYDROUS FILL FORMULATION FOR ULTRAVIOLET FILTERS | SCHERER TECHNOLOGIES LLC R P (US) | 2020-07-29 | — | — | EP | claimed |
| EP-2853255-B1 | Method of formulating a personal care product with substantially no whitening effect when applied on wet skin and compositions thereof | HallStar Beauty and Personal Care Innovations Company (US) | 2018-11-28 | — | — | EP | claimed |
| EP-3056192-B1 | Complete anhydrous sunscreen composition with under water technology | FREZYDERM S A (GR) | 2018-11-21 | — | — | EP | claimed |
| EP-3195849-A1 | UV BLOCKING FUNCTIONAL COMPOSITE POWDER PREPARED BY DOUBLY COATING INORGANIC POWDER WITH INORGANIC UV BLOCKING AGENT AND ORGANIC UV ABSORBER, AND UV BLOCKING COSMETIC COMPOSITION USING SAME | Chemland. Co., Ltd. (KR) | 2017-07-26 | — | — | EP | claimed |
| EP-1594454-B1 | FILM FORMING HYDROALCOHOLIC FOAM | STIEFEL RES AUSTRALIA PTY LTD (AU) | 2016-07-27 | — | — | EP | claimed |
| US-9211237-B2 | Film foaming hydroalcoholic foam | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2015-12-15 | — | — | US | claimed |
| US-20140017176-A1 | FILM FOAMING HYDROALCOHOLIC FOAM | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2014-01-16 | — | — | US | claimed |
| EP-1782792-B1 | Ultraviolet ray absorbing composite powder | IWASE COSFA CO LTD (JP) | 2013-01-09 | — | — | EP | claimed |
| EP-1360146-B1 | PROCESS FOR THE PREPARATION OF AQUEOUS SUSPENSIONS OF ANIONIC COLLOIDAL SILICA HAVING A NEUTRAL PH AND APPLICATIONS THEREOF | AZ ELECTRONIC MATERIALS USA (US) | 2012-06-13 | — | — | EP | claimed |
| EP-1899015-B1 | COMPOSITION WITH TIGHT CAPSULES CONTAINING A SUNSCREEN AGENT | DSM IP ASSETS BV (NL) | 2012-03-21 | — | — | EP | claimed |
| US-20060233727-A9 | Film foaming hydroalcoholic foam | CONNETICS AUSTRALIA PTY LTD. (AU) | 2006-10-19 | — | — | US | claimed |
| US-20060067894-A1 | Film foaming hydroalcoholic foam | CONNETICS AUSTRALIA PTY LTD. (AU) | 2006-03-30 | — | — | US | claimed |
| EP-1594454-A1 | FILM FORMING HYDROALCOHOLIC FOAM | Connetics Australia Pty Limited (AU) | 2005-11-16 | — | — | EP | claimed |
| EP-1059911-B1 | FORMULATIONS WITH AN ANTI-VIRAL EFFECT | MERCK PATENT GMBH (DE) | 2005-04-20 | — | — | EP | claimed |
| WO-2004071479-A1 | FILM FOAMING HYDROALCOHOLIC FOAM | CONNETICS AUSTRALIA PTY LTD (AU) | 2004-08-26 | — | — | WO | claimed |
| EP-1059911-A1 | FORMULATIONS WITH AN ANTI-VIRAL EFFECT | MERCK PATENT GmbH (DE) | 2000-12-20 | — | — | EP | claimed |
| WO-1999044578-A1 | FORMULATIONS WITH AN ANTI-VIRAL EFFECT | MERCK PATENT GMBH (DE) | 1999-09-10 | — | — | WO | claimed |
| EP-0509904-B1 | Microencapsulation of sunscreen products, their preparation process, cosmetic and pharmaceutical compositions containing said microcapsules and their applications | ROUSSEL UCLAF (FR) | 1996-02-28 | — | — | EP | claimed |
| EP-4037636-A1 | ANTI-UV COSMETIC COMPOSITION | Coatex (FR) | 2022-08-10 | — | — | EP | disclosed |
| WO-2021064299-A1 | ANTI-UV COSMETIC COMPOSITION | COATEX (FR) | 2021-04-08 | — | — | WO | disclosed |
| EP-2775997-B1 | COSMETIC AND DERMATOLOGICAL PHOTOPROTECTIVE PREPARATION WITH IMPROVED WATER RESISTANCE | BEIERSDORF AG (DE) | 2019-08-07 | — | — | EP | disclosed |
| US-20190038538-A1 | RNA COMPLEXES THAT INHIBIT MELANIN PRODUCTION | OLIX PHARMACEUTICALS, INC. (KR) | 2019-02-07 | — | — | US | disclosed |
| US-10064801-B2 | RNA complexes that inhibit melanin production | OLIX PHARMACEUTICALS, INC. (KR) | 2018-09-04 | — | — | US | disclosed |
| EP-2210619-B1 | Scar covering with UV protection | BEIERSDORF AG (DE) | 2017-12-20 | — | — | EP | disclosed |
| EP-3195849-A1 | UV BLOCKING FUNCTIONAL COMPOSITE POWDER PREPARED BY DOUBLY COATING INORGANIC POWDER WITH INORGANIC UV BLOCKING AGENT AND ORGANIC UV ABSORBER, AND UV BLOCKING COSMETIC COMPOSITION USING SAME | Chemland. Co., Ltd. (KR) | 2017-07-26 | — | — | EP | disclosed |
| WO-2017017523-A1 | RNA COMPLEXES THAT INHIBIT MELANIN PRODUCTION | OLIX PHARMACEUTICALS, INC. (KR) | 2017-02-02 | — | — | WO | disclosed |
| US-20170027837-A1 | RNA COMPLEXES THAT INHIBIT MELANIN PRODUCTION | OLIX PHARMACEUTICALS, INC. (KR) | 2017-02-02 | — | — | US | disclosed |
| EP-1594454-B1 | FILM FORMING HYDROALCOHOLIC FOAM | STIEFEL RES AUSTRALIA PTY LTD (AU) | 2016-07-27 | — | — | EP | disclosed |
| US-9265726-B2 | Foamable suspension gel | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2016-02-23 | — | — | US | disclosed |
| WO-2016005689-A1 | USE OF AN AMINATED HOMOPOLYMER FOR ENCAPSULATING INGREDIENTS, METHOD OF SYNTHESIZING AN AEMA HOMOPOLYMER AND METHOD OF ENCAPSULATING INGREDIENTS | ISP INVESTMENTS INC. (US) | 2016-01-14 | — | — | WO | disclosed |
| WO-2016005693-A1 | STATISTICAL CATIONIC COPOLYMERS, METHOD FOR THEIR SYNTHESIS AND THEIR USE FOR INGREDIENT ENCAPSULATION | ISP INVESTMENTS INC. (US) | 2016-01-14 | — | — | WO | disclosed |
| US-9211237-B2 | Film foaming hydroalcoholic foam | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2015-12-15 | — | — | US | disclosed |
| EP-2206494-B1 | Foamable suspension gel | STIEFEL RES AUSTRALIA PTY LTD (AU) | 2015-12-02 | — | — | EP | disclosed |
| US-9012418-B2 | Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) | L'OREAL (FR) | 2015-04-21 | — | — | US | disclosed |
| US-20140248220-A1 | FOAMABLE SUSPENSION GEL | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2014-09-04 | — | — | US | disclosed |
| US-8758728-B2 | Foamable suspension gel | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2014-06-24 | — | — | US | disclosed |
| EP-2688650-A1 | FILM-FORMING COMPOSITION CONTAINING A SUN FILTER, AND USE THEREOF FOR THE TREATMENT OF SCARS | Laboratoires Urgo (FR) | 2014-01-29 | — | — | EP | disclosed |
| US-20140017176-A1 | FILM FOAMING HYDROALCOHOLIC FOAM | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2014-01-16 | — | — | US | disclosed |
| US-20130280309-A1 | FOAMABLE SUSPENSION GEL | STIEFEL RESEARCH AUSTRALIA PTY LTD. (AU) | 2013-10-24 | — | — | US | disclosed |
| US-8562959-B2 | Film foaming hydroalcoholic foam | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2013-10-22 | — | — | US | disclosed |
| US-8475770-B2 | Foamable suspension gel | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2013-07-02 | — | — | US | disclosed |
| EP-2209462-B1 | Cosmetic product for protecting the skin from environmental influences | COTY GERMANY GMBH (DE) | 2013-04-10 | — | — | EP | disclosed |
| WO-2012131237-A1 | FILM-FORMING COMPOSITION CONTAINING A SUN FILTER, AND USE THEREOF FOR THE TREATMENT OF SCARS | LABORATOIRES URGO (FR) | 2012-10-04 | — | — | WO | disclosed |
| US-8158109-B2 | Foamable suspension gel | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2012-04-17 | — | — | US | disclosed |
| US-20110318278-A1 | FOAMABLE SUSPENSION GEL | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2011-12-29 | — | — | US | disclosed |
| EP-2210619-A2 | Scar covering with UV protection | Beiersdorf AG (DE) | 2010-07-28 | — | — | EP | disclosed |
| EP-2206494-A1 | Foamable suspension gel | Stiefel Research Australia Pty Ltd (AU) | 2010-07-14 | — | — | EP | disclosed |
| EP-2181698-A2 | Cosmetic formula with siloxane elastomers and particulate material | Beiersdorf AG (DE) | 2010-05-05 | — | — | EP | disclosed |
| EP-2181699-A1 | Cosmetic formula with siloxane elastomers for improving microbiological stability | Beiersdorf AG (DE) | 2010-05-05 | — | — | EP | disclosed |
| EP-2179721-A1 | Cosmetic formula with new siloxane elastomers | Beiersdorf AG (DE) | 2010-04-28 | — | — | EP | disclosed |
| US-20090117063-A1 | Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) | DURANTON ALBERT | 2009-05-07 | — | — | US | disclosed |
| EP-2010133-A2 | FOAMABLE SUSPENSION GEL | Stiefel Research Australia Pty Ltd (AU) | 2009-01-07 | — | — | EP | disclosed |
| EP-1748753-B1 | BENZYLIDENEN-ßDICARBONYL COMPOUNDS AS NOVEL UV-ABSORBERS | SYMRISE GMBH & CO KG (DE) | 2008-10-01 | — | — | EP | disclosed |
| EP-1961453-A2 | Benzyliden-ß-dicarbonyl compounds as UV-absorbers | Symrise GmbH & Co. KG (DE) | 2008-08-27 | — | — | EP | disclosed |
| WO-2008007224-A2 | FOAMABLE SUSPENSION GEL | STIEFEL RESEARCH AUSTRALIA PTY LTD (US) | 2008-01-17 | — | — | WO | disclosed |
| US-20070237724-A1 | Foamable suspension gel | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2007-10-11 | — | — | US | disclosed |
| EP-1778175-A1 | ALPHA-BENZOYL-CINNAMIC ACID NITRILE AS NOVEL UV-ABSORBERS | Symrise GmbH & Co. KG (DE) | 2007-05-02 | — | — | EP | disclosed |
| EP-1748753-A1 | BENZYLIDENEN-ßDICARBONYL COMPOUNDS AS NOVEL UV-ABSORBERS | Symrise GmbH & Co. KG (DE) | 2007-02-07 | — | — | EP | disclosed |
| US-20060233727-A9 | Film foaming hydroalcoholic foam | CONNETICS AUSTRALIA PTY LTD. (AU) | 2006-10-19 | — | — | US | disclosed |
| EP-1642560-A1 | Sunscreen and skincare compositions containing DNA-repairing enzymes | STADA ARZNEIMITTEL AG (DE) | 2006-04-05 | — | — | EP | disclosed |
| US-20060067894-A1 | Film foaming hydroalcoholic foam | CONNETICS AUSTRALIA PTY LTD. (AU) | 2006-03-30 | — | — | US | disclosed |
| WO-2006015954-A1 | ALPHA-BENZOYL-CINNAMIC ACID NITRILE AS NOVEL UV-ABSORBERS | SYMRISE GMBH & CO. KG (DE) | 2006-02-16 | — | — | WO | disclosed |
| WO-2005107692-A1 | BENZYLIDENE-β-DICARBONYL COMPOUNDS AS NOVEL UV-ABSORBERS | SYMRISE GMBH & CO. KG (DE) | 2005-11-17 | — | — | WO | disclosed |
| EP-1594454-A1 | FILM FORMING HYDROALCOHOLIC FOAM | Connetics Australia Pty Limited (AU) | 2005-11-16 | — | — | EP | disclosed |
| US-20050222071-A1 | Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) | L'OREAL (FR) | 2005-10-06 | — | — | US | disclosed |
| EP-1059911-B1 | FORMULATIONS WITH AN ANTI-VIRAL EFFECT | MERCK PATENT GMBH (DE) | 2005-04-20 | — | — | EP | disclosed |
| EP-1466892-A1 | Novel indanylidene compounds | Symrise GmbH & Co. KG (DE) | 2004-10-13 | — | — | EP | disclosed |
| WO-2004071479-A1 | FILM FOAMING HYDROALCOHOLIC FOAM | CONNETICS AUSTRALIA PTY LTD (AU) | 2004-08-26 | — | — | WO | disclosed |
| EP-1341752-B1 | NOVEL INDANYLIDENE COMPOUNDS | SYMRISE GMBH & CO KG (DE) | 2004-08-04 | — | — | EP | disclosed |
| US-20040057917-A1 | Pharmaceutical composition for treatment and /or prevention of a light-dermatosis | HANS-DIETER PRENTNER (AT) | 2004-03-25 | — | — | US | disclosed |
| WO-2003092643-A1 | LIGHT-PROTECTION FORMULATIONS USING ACRYLONITRILE DERIVATIVES | SYMRISE GMBH & CO. KG (DE) | 2003-11-13 | — | — | WO | disclosed |
| EP-1341752-A1 | NOVEL INDANYLIDENE COMPOUNDS | HAARMANN & REIMER GMBH (DE) | 2003-09-10 | — | — | EP | disclosed |
| WO-2002038537-A1 | NOVEL INDANYLIDENE COMPOUNDS | HAARMANN & REIMER GMBH (DE) | 2002-05-16 | — | — | WO | disclosed |
| EP-1153600-A2 | Sunscreen and skincare compositions containing DNA-repairing enzymes | STADA ARZNEIMITTEL AG (DE) | 2001-11-14 | — | — | EP | disclosed |
| US-6265180-B1 | STERILE NONTOXIC DISPERSION FOR USE IN TRANSFERRING MATERIALS INTO CELLS | MIBELLE AG COSMETICS (CH) | 2001-07-24 | — | — | US | disclosed |
| US-6265180-B1 | STERILE NONTOXIC DISPERSION FOR USE IN TRANSFERRING MATERIALS INTO CELLS | MIBELLE AG COSMETICS (CH) | 2001-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050222071-A1 | Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) | DCLRE1B, POLRMT, ADAR | PTGER3 4810/4885PTGER4 4713/4885PTGER2 4814/4885 |
| US-20090117063-A1 | Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) | DCLRE1B, POLRMT, ADAR | PTGER3 4810/4885PTGER4 4713/4885PTGER2 4814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.